Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment

Multiple Myeloma (MM) is a hematologic malignancy characterized by clonal plasma cell development, leading to serious complications. Despite traditional treatments, MM remains incurable, necessitating innovative therapeutic approaches. Chimeric Antigen Receptor (CAR) T-cell therapy and Bispecific T-...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Rahul Navab, Pragyat Futela, Verkha Kumari, Jayesh Valecha, Ramansh Bandhu Gupta, Rohit Jain
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Shiraz University of Medical Sciences 2025-01-01
Sarja:	Iranian Journal of Medical Sciences
Aiheet:	multiple myeloma car t-cell therapy bispecific antibodies immunotherapy
Linkit:	https://ijms.sums.ac.ir/article_50407_ad2eaf591bada72e1e5d479cee299d69.pdf
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!